B Olsson-Liljequist

17.9k total citations · 1 hit paper
77 papers, 12.0k citations indexed

About

B Olsson-Liljequist is a scholar working on Molecular Medicine, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, B Olsson-Liljequist has authored 77 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Medicine, 30 papers in Epidemiology and 28 papers in Clinical Biochemistry. Recurrent topics in B Olsson-Liljequist's work include Antibiotic Resistance in Bacteria (31 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Antimicrobial Resistance in Staphylococcus (24 papers). B Olsson-Liljequist is often cited by papers focused on Antibiotic Resistance in Bacteria (31 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Antimicrobial Resistance in Staphylococcus (24 papers). B Olsson-Liljequist collaborates with scholars based in Sweden, United States and Norway. B Olsson-Liljequist's co-authors include Gunnar Kahlmeter, Christian G. Giske, Stéphan Harbarth, Dominique L. Monnet, Anna-Pelagia Magiorakos, Arjun Srinivasan, J. Todd Weber, John Stelling, Louis B. Rice and Marc Struelens and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

B Olsson-Liljequist

77 papers receiving 11.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

2011 10.1k citations Anna-Pelagia Magiorakos, Arjun Srinivasan et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Olsson-Liljequist Sweden	28	7.0k	3.1k	2.5k	2.4k	2.3k	77	12.0k
Janet Hindler United States	14	6.5k 0.9×	2.5k 0.8×	2.3k 0.9×	2.4k 1.0×	2.4k 1.0×	30	11.1k
J. Todd Weber United States	17	6.5k 0.9×	2.8k 0.9×	2.4k 1.0×	2.3k 0.9×	2.0k 0.9×	28	11.3k
Roberta B. Carey United States	19	6.9k 1.0×	2.9k 1.0×	2.5k 1.0×	2.8k 1.2×	3.5k 1.5×	37	13.1k
Alkiviadis Vatopoulos Greece	31	8.6k 1.2×	2.8k 0.9×	3.3k 1.3×	2.7k 1.1×	2.1k 0.9×	77	13.0k
Anna-Pelagia Magiorakos Sweden	10	6.9k 1.0×	2.5k 0.8×	2.4k 1.0×	2.2k 0.9×	2.0k 0.8×	12	11.2k
John Stelling United States	19	6.8k 1.0×	2.7k 0.9×	2.3k 0.9×	2.3k 1.0×	1.9k 0.8×	68	11.6k
Peter M. Hawkey United Kingdom	63	6.6k 0.9×	3.6k 1.2×	2.9k 1.2×	3.5k 1.4×	4.5k 1.9×	247	14.9k
Luis Martínez‐Martínez Spain	57	8.7k 1.2×	2.6k 0.8×	3.9k 1.6×	2.8k 1.2×	1.5k 0.6×	330	12.0k
Patricia A. Bradford United States	52	9.0k 1.3×	1.9k 0.6×	3.0k 1.2×	2.6k 1.1×	1.6k 0.7×	122	11.6k
Álvaro Pascual Spain	59	10.3k 1.5×	4.2k 1.4×	4.0k 1.6×	2.6k 1.1×	1.9k 0.8×	404	14.3k

Countries citing papers authored by B Olsson-Liljequist

Since Specialization

Citations

This map shows the geographic impact of B Olsson-Liljequist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Olsson-Liljequist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Olsson-Liljequist more than expected).

Fields of papers citing papers by B Olsson-Liljequist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Olsson-Liljequist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Olsson-Liljequist. The network helps show where B Olsson-Liljequist may publish in the future.

Co-authorship network of co-authors of B Olsson-Liljequist

This figure shows the co-authorship network connecting the top 25 collaborators of B Olsson-Liljequist. A scholar is included among the top collaborators of B Olsson-Liljequist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Olsson-Liljequist. B Olsson-Liljequist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Börjesson, Stefan, Cecilia Jernberg, Alma Brolund, et al.. (2013). Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates. Clinical Microbiology and Infection. 19(7). E309–E311. 38 indexed citations

Magiorakos, Anna-Pelagia, Arjun Srinivasan, Roberta B. Carey, et al.. (2011). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection. 18(3). 268–281. 10072 indexed citations breakdown →

Brolund, Alma, Sara Hæggman, Petra Edquist, et al.. (2010). The DiversiLab system versus pulsed-field gel electrophoresis: Characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. Journal of Microbiological Methods. 83(2). 224–230. 47 indexed citations

Giske, Christian G., et al.. (2009). Interplay of Efflux, Impermeability, and AmpC Activity Contributes to Cefuroxime Resistance in Clinical, Non-ESBL-Producing Isolates of Escherichia coli. Microbial Drug Resistance. 15(2). 91–95. 14 indexed citations

Högberg, Liselotte Diaz, Karl Ekdahl, Karin Sjöström, et al.. (2006). Penicillin-Resistant Pneumococci in Sweden 1997–2003: Increased Multiresistance Despite Stable Prevalence and Decreased Antibiotic Use. Microbial Drug Resistance. 12(1). 16–22. 16 indexed citations

Österlund, Anders, et al.. (2006). Staphylococcus aureus resistant to fusidic acid among Swedish children: A follow-up study. Scandinavian Journal of Infectious Diseases. 38(5). 332–334. 24 indexed citations

Hedberg, Anders, et al.. (2004). Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis. Clinical Microbiology and Infection. 10(8). 765–768. 8 indexed citations

Sandgren, Andreas, et al.. (2004). Effect of Clonal and Serotype‐Specific Properties on the Invasive Capacity ofStreptococcus pneumoniae. The Journal of Infectious Diseases. 189(5). 785–796. 182 indexed citations

Hanberger, Håkan, Lars Burman, Otto Cars, et al.. (2004). High antibiotic susceptibility among bacterial pathogens in Swedish ICUs Report from a nation-wide surveillance program using TA₉₀as a novel index of susceptibility. Scandinavian Journal of Infectious Diseases. 36(1). 24–30. 34 indexed citations

10.

Normark, Birgitta Henriques, Birger Christensson, Andreas Sandgren, et al.. (2003). Clonal Analysis of Streptococcus pneumoniae Nonsusceptible to Penicillin at Day-Care Centers with Index Cases, in a Region with Low Incidence of Resistance: Emergence of an Invasive Type 35B Clone among Carriers. Microbial Drug Resistance. 9(4). 337–344. 36 indexed citations

11.

Iversen, Aina, Inger Kühn, Mokhlasur Rahman, et al.. (2003). Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium. Environmental Microbiology. 6(1). 55–59. 66 indexed citations

12.

Goettsch, Wim, S L A M Bronzwaer, Albert J. de Neeling, et al.. (2000). Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS)†. Clinical Microbiology and Infection. 6(2). 59–63. 20 indexed citations

13.

Wreiber, Karin, B Olsson-Liljequist, & Lars Engstrand. (1999). [Development of resistant Helicobacter pylori in Sweden. Tendency toward increasing resistance to clarithromycin].. PubMed. 96(6). 582–4. 10 indexed citations

14.

Hedlund, J. & B Olsson-Liljequist. (1997). [A handling program for resistant pneumococci. Physicians sometimes neglect mandatory notification].. PubMed. 94(51-52). 4914–8. 1 indexed citations

15.

Olsson-Liljequist, B & Lars Burman. (1993). Introducing Fosfomycin for Surgical Prophylaxis-Emergence of Resistance in Aerobic Faecal Gram-negative Bacteria of In-patients, but Not Among Strains Causing Infection after Elective Colorectal Procedures. Scandinavian Journal of Infectious Diseases. 25(6). 725–733. 11 indexed citations

16.

Olsson-Liljequist, B. (1992). E-Test as a routine MIC tool for reference work. Diagnostic Microbiology and Infectious Disease. 15(5). 479–482. 6 indexed citations

17.

Olsson-Liljequist, B, Lars Burman, Ingegerd Kallings, et al.. (1992). Antibiotic Susceptibility of Upper Respiratory Tract Pathogens in Sweden: A Seven Year Follow-up Study Including Loracarbef. Scandinavian Journal of Infectious Diseases. 24(4). 485–493. 25 indexed citations

18.

Tullus, Kjell, et al.. (1991). Antibiotic Susceptibility of 629 Bacterial Blood and CSF Isolates from Swedish Infants and the Therapeutic Implications. Acta Paediatrica. 80(2). 205–212. 20 indexed citations

19.

Johansen, K, Marie Eriksson, B Olsson-Liljequist, & G. Stintzing. (1989). Absorption of Erythromycin in Children with Gluten Intolerance. Acta Paediatrica. 78(6). 959–960. 1 indexed citations

20.

Olsson-Liljequist, B & Nord Ce. (1981). [Antibiotic resistance among anaerobic bacteria].. PubMed. 78(45). 4032–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact